ListarRESULTADOS DE INVESTIGACIÓN por tema "pre-exposure prophylaxis"
Mostrando ítems 1-4 de 4
-
Advances in long-acting slow effective release antiretroviral therapies for treatment and prevention of HIV infection
(Advanced Drug Delivery Reviews, 2023)Adherence to daily oral antiretroviral therapy (ART) is a barrier to both treatment and prevention of human immunodeficiency virus (HIV) infection. To overcome limitations of life-long daily regimen adherence, longacting ... -
Occult hepatitis B and HIV infection
(European Journal of Gastroenterology & Hepatology, 11/2019)Introduction Occult hepatitis B virus (HBV) infection, so-called occult B infection (OBI), is defined by the recognition of HBV-DNA in the absence of serum hepatitis B surface antigen (HBsAg). The HBV-DNA genome in OBI is ... -
Rebound in Sexually Transmitted Infections Following the Success of Antiretrovirals for HIV/AIDS
(AIDS Reviews, 10/2018)Nearly 1 million people become infected every day with any of the four major curable sexually transmitted infections (STIs), namely trichomoniasis, chlamydia, gonorrhea, and syphilis. Despite huge global incidence, STIs ... -
Ultra-long-acting antivirals as chemical vaccines to prevent viral diseases
(Future Microbiology, 07/2022)For two centuries, vaccines have been successful in the fight against viruses, triggering immune protection. Indeed, the elimination of smallpox, the only infectious disease eradicated to date, was made possible through ...
